Editorial: Molecular mechanisms of proteinuria, volume II.
作者信息
Daehn Ilse S, Merscher Sandra
机构信息
Division of Nephrology, Department of Medicine, The Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Katz Family Division of Nephrology and Hypertension, Department of Medicine, Peggy and Harold Katz Family Drug Discovery Center, University of Miami, Miami, FL, United States.
出版信息
Front Med (Lausanne). 2022 Oct 13;9:1026202. doi: 10.3389/fmed.2022.1026202. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Molecular mechanisms of proteinuria, volume II.
Front Med (Lausanne). 2022 Oct 13;9:1026202. doi: 10.3389/fmed.2022.1026202. eCollection 2022.
2
Normal and abnormal aspects of proteinuria. Part I: Mechanisms, characteristics and analyses of urinary protein. Part II: Clinical considerations.
Exp Pathol. 1986;29(1):1-28. doi: 10.1016/s0232-1513(86)80002-0.
3
Editorial: Massive proteinuria associated with chronic pyelonephritis.
Urology. 1973 Nov;2(5):588-90. doi: 10.1016/0090-4295(73)90580-3.
4
MECHANISMS OF PROTEINURIA.
Biochem Clin. 1963;2:171-82.
5
The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia.
J Clin Invest. 1972 Aug;51(8):2162-74. doi: 10.1172/JCI107023.
6
[NEW FINDINGS ON THE STRUCTURAL CHANGES OF THE CAPILLARY WALL OF THE GLOMERULUS IN PROTEINURIA].
Arch Pediatr Urug. 1965 Apr;36:209-20.
7
Increased dynamin expression precedes proteinuria in glomerular disease.
J Pathol. 2019 Feb;247(2):177-185. doi: 10.1002/path.5181. Epub 2018 Nov 27.
8
Workup for proteinuria.
Prim Care. 2014 Dec;41(4):719-35. doi: 10.1016/j.pop.2014.08.010. Epub 2014 Sep 27.
9
Postexercise proteinuria in humans. Facts and mechanisms.
JAMA. 1985 Jan 11;253(2):236-40.
10
Symptomless abnormalities proteinuria.
Br J Hosp Med. 1982 Mar;27(3):254-6, 258.
本文引用的文献
1
Similarities and Differences between COVID-19-Associated Nephropathy and HIV-Associated Nephropathy.
Kidney Dis (Basel). 2021 Nov 29;8(1):1-12. doi: 10.1159/000520235. eCollection 2022 Jan.
2
The glomerular filtration barrier: a structural target for novel kidney therapies.
Nat Rev Drug Discov. 2021 Oct;20(10):770-788. doi: 10.1038/s41573-021-00242-0. Epub 2021 Jul 14.
3
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials.
Lancet Diabetes Endocrinol. 2019 Feb;7(2):128-139. doi: 10.1016/S2213-8587(18)30314-0. Epub 2019 Jan 8.
4
Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.
Lancet Diabetes Endocrinol. 2019 Feb;7(2):115-127. doi: 10.1016/S2213-8587(18)30313-9. Epub 2019 Jan 8.
5
The spectrum of systemic involvement in adults presenting with renal lesion and mitochondrial tRNA(Leu) gene mutation.
J Am Soc Nephrol. 2003 Aug;14(8):2099-108. doi: 10.1097/01.asn.0000080180.51098.02.
Zotero 插件